FTC sues key pharmacy advantage managers around insulin selling prices The agency brought motion in opposition to Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record price of daily life-conserving insulin medicines. Elevance lowers assistance on ‘unprecedented’ Medicaid troubles Executives claimed the https://arizona-hard-tea-nutritio41738.qodsblog.com/30690184/facts-about-healthcare-news-revealed